Ketoprofen 10% Cream for Treatment of Pain Associated With Mild to Moderate Acute Soft Tissue Injury
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Transdel Pharmaceuticals is investigating a topical cream formulation consisting of 10%
ketoprofen for the local treatment of pain associated with mild to moderate acute soft tissue
injury in this confirmatory Phase 3 trial.